GBA1 and Parkinson disease: In this PD model, alterations of GBA and GCase substrates, glycolipids glucosylceramide (GlcCer), and glucosylsphingosine (GlcSph) are found at increased levels, resulting in defective action of cellular organelles of neurons, making neurons more vulnerable to apoptosis [169].